It can't happen here - can it? by Petsko, Gregory A
Genome Biology 2007, 8:105
Comment
It can’t happen here - can it?
Gregory A Petsko
Address: Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, MA 02454-9110, USA. 
Email: petsko@brandeis.edu
Published: 30 April 2007
Genome Biology 2007, 8:105 (doi:10.1186/gb-2007-8-4-105)
The electronic version of this article is the complete one and can be
found online at http://genomebiology.com/2007/8/4/105
© 2007 BioMed Central Ltd 
If scientific advice is to have any value, it must come from
sources that are not under obligation to any organization,
public or private. In the United Kingdom, that advice
generally comes from the Royal Society of London. In the
United States, it comes from the National Academy of
Sciences. And in much of the former Soviet Union, it comes
from the Russian Academy of Sciences. You wouldn’t
necessarily think they would have similar ideas about the
importance of independence, but they do.
The oldest scientific society still in existence, the Royal
Society of London, was founded in 1660. Its permanent
Second Charter received the Royal Seal on the 23 April 1663.
The motto of the Society, “Nullius in Verba” (“On the words
of no one”), signifies the Society’s commitment to
establishing the truth of scientific matters through
experiment rather than through the words of any authority.
The Society is governed by its Council of Trustees, which is
chaired by its President. The members of the Council and the
President are elected from its Fellowship, new members of
which are in turn elected by vote of the existing Fellows. The
Royal Society has never depended on the Crown for either its
finances or its governance.
The National Academy of Sciences of the United States was
created in 1863 by a congressional charter approved by
President Abraham Lincoln. The key part of the charter
specifies the relationship between the Academy and the
government. The Academy was created to be an adviser on
scientific and technological matters, but the Academy and its
associated organizations are private, nongovernmental
organizations and do not receive direct federal appropria-
tions for any of their work. (Studies undertaken for the
government by the National Academies usually are funded
out of appropriations made available to federal agencies.) The
charter stipulates virtually complete autonomy for the
Academy, including freedom to elect its members and officers
and establish its own policies and procedures.
I could tell similar stories about the principal scientific
organizations in most Western countries. Though the precise
relationship between the state and scientific community
varies in detail, for the most part there is at least a large
measure of autonomy in scientific advice, and considerable
nongovernmental scientific input into funding decisions and
research directions. In short, the principle of independence
from state control has guided the formation and governance
of every scientific society in the world whose opinions have
any credibility.
If Russian president Vladimir Putin has his way, that
principle will no longer apply to the Russian Academy of
Sciences. (During the period when Russia was part of the
Soviet Union it was known as the Academy of Sciences of the
USSR.) The Academy was founded in January 1724 in St.
Petersberg by Peter the Great. For most of its existence it
was effectively an arm of the government, and in 1917, Lenin
decided that the Academy would address questions of state
construction, in return for which the Soviet regime would
give the Academy financial and political support. Partly to
reflect this connectedness, its headquarters were moved to
Moscow, the Soviet capital, in 1934.
But a curious thing happened during the post-Stalinist era:
despite its close ties with the state, the Russian Academy
began to assert its independence in many important matters.
It frequently rejected for membership senior Communist
Party officials whom it considered unqualified. In 1980, it
refused to expel dissident nuclear physicist Andrei Sakharov,
despite demands from Moscow that it do so. (Disclosure:
much of my knowledge of the inner workings of the Russian
Academy and scientific politics in Russia comes from
conversations I had over the years with my good friend
Vitalii Goldanski, who died in 2001. Vitalii, who was born in
Belarus in 1923, was a great chemical and nuclear physicist.
In addition to being a member of the Russian Academy, he
was also a member of the Supreme Soviet and the Congressof People’s Deputies. In 1991 he was honored by the New
York Academy of Sciences for his work on behalf of nuclear
disarmament.)
The Russian Academy has also tried to retain at least partial
autonomy over what science was funded. Unlike the
American and British scientific academies, whose primary
functions are honorific and advisory, the Russian Academy
effectively controls much of the scientific research in its
country. The Academy’s senior members oversee a $1.2
billion budget, 400 research institutes and 200,000 resear-
chers and staff members across Russia. And just like most
other Western academies, the institution is self-governing:
research funding, as well as who becomes a researcher and
who enjoys the prestigious title of full member -
‘academician’ - is determined by secret ballot among the
members. Although over the years, the government has
directed the Academy to support a number of specific areas
of science, not all of these directives were accepted and the
Academy was able to keep many areas of research alive
against the wishes of the communist authorities. It is this
tradition of political independence that Vladimir Putin is
trying to eliminate.
Putin used to be a member of the KGB (Komitet
Gosudarstvennoy Bezopasnosti, the Committee for State
Security), the notorious combined intelligence and secret
police organization that terrorized the Soviet Union for
decades under communist rule. Lately he seems to be
showing signs of wanting to take up his old hobbies. Last
year, at Putin’s urging, the Russian Parliament passed a law
stipulating that the Academy’s top executive must be
approved by the president and that its charter must be
approved by the government. Shortly thereafter, the
Education Ministry, to which the Academy reports, proposed
a new charter that would create an advisory council with
nine members, only three of whom would be scientists; the
other six would be a mixture of government officials,
lawmakers, and ministers. This body would oversee all of the
operations of the Academy, including the funding of
research, and would make all decisions about what areas of
science would be pursued. In other words, control of the
operation of the Academy would be ceded to the state.
As might be expected, the Academy is fighting this proposal. A
few weeks ago its senior members voted unanimously against
the proposed charter. Given the tight control that Putin has
established over virtually all aspects of Russian life, it remains
to be seen if their courageous assertion of independence will
prevail. (One thing is certain: they can use all the support they
can get from their friends outside Russia.)
Before we in the West congratulate ourselves on being
fortunate enough to live in countries where science is
independent of state control, maybe we should take a close
look at recent developments here. The Bush Administration
hasn’t tried to take over the scientific establishment, not
because they don’t want to (this is an administration that
aspires to rule, not govern), but rather because they don’t
have to - they’ve simply ignored every objective scientific fact
or report that didn’t fit their ideologically driven policy
goals. Why bother taking over what you can marginalize?
True, they have tried staffing some federal scientific
administrative posts with people who have minimal - in
some cases, nonexistent - scientific credentials. Frequently
these appointees appear to have been chosen for their
fundamentalist religious, social conservative, or free-market
beliefs. It’s hard to assess the full measure of harm that has
caused (environmental issues seem to have been most
affected), but it hasn’t had much of a direct impact on the
scientific community as a whole, as far as I can tell.
But the independence of American science is being eroded
nonetheless. And as is so often the case, this particular
road to hell has been paved with the best of intentions, and
the street plan was designed, not by our enemies, but by
our friends.
It started, as so much has in the past decade, with the
Human Genome Initiative. I have said before, and will say to
the end of my days, that this project, wonderful and
important as it has been, was oversold to the US Congress
and the public. By promising that cures for diseases would
emerge, as if by magic, from the oceans of data that were
generated, the founders of that project and the funding-
agency administrators who supported them raised expecta-
tions that simply couldn’t be met in any reasonable period of
time. Out of concern that lawmakers and their constituents
would, quite reasonably, soon hold them to account, the
administrators in the US National Institutes of Health (NIH)
began a campaign to shift some of the science they suppor-
ted away from basic investigations and towards translational
research that was more directly focused on human diseases.
That focus became the basis for selling Congress on another,
even larger expenditure: a doubling of the NIH budget over
about a seven-year period. Congress acquiesced to the
doubling, which was completed a few years ago, in large part
because it bought the argument that the investment in
genomics would only pay off with a concomitant investment
in its applications.
During the doubling I think there was a sense that there
would be a surplus of money, which led many administrators
to conceive of big projects that would give them, and their
institutes, the same high-profile success as that enjoyed by
the Human Genome Institute. In this, they were abetted by
many from our own ranks of independent investigators, who
wanted their share of the money and glory that had gone to
the Craig Venters, Eric Landers, and Francis Collins’ of the
genomics projects. What followed was a subtle, but rapid
shift in how scientific priorities are set. Instead of research
directions arising largely from the open competition of
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setting those directions itself through increased numbers of
big new programs and specific allocation of large pots of
money for certain types of projects - commonly, projects
aimed at either exploiting the information from genomics
studies or gathering more.
Such projects, consequently, have relatively stable funding,
but individual investigator-initiated projects do not. As I’ve
written before (The System is Broken, Genome Biol 2006,
7:105 and Instructions for Repair,  Genome Biol 2006,
7:106), the result has been a disaster for American science.
Funding of regular research grants is so tight that many mid-
career investigators are being driven out of research; senior
investigators, whose perspective is needed more than ever,
are being driven into early retirement; and good young
investigators are seeing their careers at the mercy of a
process that, quite literally, is no better than a lottery. How
have the funding agencies responded to this crisis? I know
many administrators who are personally dismayed at the
situation, but the culture seems to have developed some
huge inertia: ironically, after the doubling of the NIH
budget, when the crisis has been made worse by no budget
increases for several years, the number of grants funded
through government-initiated requests for applications and
program announcements has increased even more than they
did during the doubling. And the percentage of new awards
that go to traditional basic science research projects has
continued to fall.
We scientists in the trenches need to reclaim our rightful
place as the setters of priorities and directions. One way to do
this is to fix the peer-review system, so that once again the
most creative and productive investigators are funded, and
the importance of the question being addressed, not whether
something fits into some preconceived program, largely
governs what research gets supported. Another way is to
demand - and play - a greater role in determining how big
scientific funding decisions are made. To be fair, science
administrators often hold workshops designed to give them
advice about important areas to support, but many in the
research community pay little attention to requests to attend.
That needs to change. I also think it’s time we started
initiating that sort of process ourselves instead of waiting for
the NIH to do so. The various scientific societies could take
the lead in establishing such a program, with the help of the
National Academy and, of course, the various NIH Institutes.
If we allow the top-down approach to determine what
science gets done, the combined pressures of human ego and
the need to make good on extravagant promises will
continue to take science where it’s already heading: towards
big, flashy, but ultimately conservative, risk-averse, un-
exciting research. We’ll produce a lot more data but fewer
discoveries. We’ll have predictability instead of surprises.
Gone will be the marvelous principle that created perhaps
the most successful scientific enterprise the world has ever
seen: that the best path to innovation is that followed by
hypothesis-driven, investigator-initiated inquiry. The Bush
Administration won’t have killed it, nor will any of our
national competitors - we will have done it to ourselves.
Vladimir Putin may well be jealous. We will have thrown
away our own independence out of greed, apathy, timidity,
and a failure of vision. And we may not even notice the irony
that the Russian Academy of Sciences will have shown more
of a commitment to freedom of inquiry than we have.
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